Procurement of Rubella Vaccine and Associated Medical Supplies for Indian Army

Work Description - NA

This tender announcement, issued by the Department of Military Affairs under the Ministry of Defence, invites bids for the procurement of Rubella Vaccine. The bid, identified by Bid Number GEM/2026/B/8002020, is being managed by the Indian Army and originates from their office located in East Khasi Hills. The tender period commences on September 6, 2026, at 10:23 AM and concludes on September 21, 2026, at 11:00 AM. The Bill of Quantities (BOQ) title is specifically "Rubella Vaccine," and the total quantity required for this item is 14,412 units. While the primary focus is Rubella Vaccine, the "Item Category" listed indicates a broader scope that may include other medical supplies such as Measles Mumps, Mifepristone 200 mg Tablets, I Gel sizes 4 and 2, Telmisartan 40 mg Tablets, Tenofovir 300 mg Tablets, Chloroxylenol Solution, Potassium Hydroxide 13.6g, Chloroxylenol solution 50.5g, Oleic acid 7.5ml, and Castrol. Bidders are advised to carefully review the detailed specifications for all listed items within the BOQ to ensure compliance with the stringent requirements of the Indian Army.